Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 23225897)

1.

A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern Tanzania.

Pearce RJ, Ord R, Kaur H, Lupala C, Schellenberg J, Shirima K, Manzi F, Alonso P, Tanner M, Mshinda H, Roper C, Schellenberg D.

J Infect Dis. 2013 Mar 1;207(5):848-59. doi: 10.1093/infdis/jis742. Epub 2012 Dec 5.

2.

The effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement.

Teboh-Ewungkem MI, Mohammed-Awel J, Baliraine FN, Duke-Sylvester SM.

Malar J. 2014 Nov 15;13:428. doi: 10.1186/1475-2875-13-428.

3.

Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New Guinea.

Barnadas C, Senn N, Iga J, Timinao L, Javati S, Malau E, Rarau P, Reeder JC, Siba P, Karunajeewa H, Zimmerman PA, Davis TM, Mueller I.

Antimicrob Agents Chemother. 2014 Nov;58(11):6958-61. doi: 10.1128/AAC.03323-14. Epub 2014 Aug 25.

4.

Assessment of the Role of Intermittent Preventive Treatment for Malaria in Infants: Letter Report.

Institute of Medicine (US) Committee on the Perspectives on the Role of Intermittent Preventive Treatment for Malaria in Infants.

Washington (DC): National Academies Press (US); 2008.

5.

Substantial increase in mutations in the genes pfdhfr and pfdhps puts sulphadoxine-pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina Faso.

Geiger C, Compaore G, Coulibaly B, Sie A, Dittmer M, Sanchez C, Lanzer M, Jänisch T.

Trop Med Int Health. 2014 Jun;19(6):690-697. doi: 10.1111/tmi.12305. Epub 2014 Mar 27.

6.

Safety of sulfadoxine/pyrimethamine for intermittent preventive treatment of malaria in infants: evidence from large-scale operational research in southern Tanzania.

Maokola W, Chemba M, Hamisi Y, Mrisho M, Shirima K, Manzi F, Masanja M, Willey B, Alonso P, Mshinda H, Tanner M, Schellenberg JR, Schellenberg D.

Int Health. 2011 Sep;3(3):154-9. doi: 10.1016/j.inhe.2011.03.009.

PMID:
24038364
7.

Monitoring antifolate resistance in intermittent preventive therapy for malaria.

Venkatesan M, Alifrangis M, Roper C, Plowe CV.

Trends Parasitol. 2013 Oct;29(10):497-504. doi: 10.1016/j.pt.2013.07.008. Epub 2013 Aug 12. Review.

8.

Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal.

Ndiaye M, Tine R, Faye B, Ndiaye JL, Diouf I, Lo AC, Sylla K, Dieng Y, Hallett R, Alifrangis M, Gaye O.

C R Biol. 2013 May-Jun;336(5-6):295-300. doi: 10.1016/j.crvi.2013.04.016. Epub 2013 Jul 18.

PMID:
23916206
9.

Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.

Crawley J, Sismanidis C, Goodman T, Milligan P; WHO Advisory Committee on serological responses to vaccines used in the Expanded Programme on Immunization in infants receiving Intermittent Preventive Treatment for malaria.

Lancet. 2012 Sep 15;380(9846):1001-10. doi: 10.1016/S0140-6736(12)60775-2. Epub 2012 Jul 30.

PMID:
22850358
10.

Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidence.

Bardají A, Bassat Q, Alonso PL, Menéndez C.

Expert Opin Pharmacother. 2012 Aug;13(12):1719-36. doi: 10.1517/14656566.2012.703651. Epub 2012 Jul 9. Review.

PMID:
22775553
11.

Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia.

Al-Farsi HM, Al-Hashami ZS, Bin Dajem SM, Al-Sheikh AA, Al-Qahtani A, Beja-Pereira A, Idris MA, Babiker HA.

Infect Genet Evol. 2012 Aug;12(6):1253-9. doi: 10.1016/j.meegid.2012.03.011. Epub 2012 Mar 28.

PMID:
22709478
13.

Cluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival.

Schellenberg JR, Maokola W, Shirima K, Manzi F, Mrisho M, Mushi A, Alonso P, Mshinda H, Tanner M, Schellenberg DM.

Malar J. 2011 Dec 30;10:387. doi: 10.1186/1475-2875-10-387.

14.

Acceptability of coupling intermittent preventive treatment in infants with the expanded programme on immunization in three francophone countries in Africa.

de Sousa A, Rabarijaona LP, Ndiaye JL, Sow D, Ndyiae M, Hassan J, Lambo N, Adovohekpe P, Guidetti F, Recht J, Affo A.

Trop Med Int Health. 2012 Mar;17(3):308-15. doi: 10.1111/j.1365-3156.2011.02915.x. Epub 2011 Nov 29.

15.

Cost-effectiveness of intermittent preventive treatment of malaria in infants (IPTi) for averting anaemia in Gabon: a comparison between intention to treat and according to protocol analyses.

Sicuri E, Biao P, Hutton G, Tediosi F, Menendez C, Lell B, Kremsner P, Conteh L, Grobusch MP.

Malar J. 2011 Oct 17;10:305. doi: 10.1186/1475-2875-10-305.

16.

Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.

Afsharpad M, Zakeri S, Pirahmadi S, Djadid ND.

Acta Trop. 2012 Jan;121(1):13-8. doi: 10.1016/j.actatropica.2011.09.010. Epub 2011 Oct 2.

PMID:
22001304
17.

Drug resistance maps to guide intermittent preventive treatment of malaria in African infants.

Naidoo I, Roper C.

Parasitology. 2011 Oct;138(12):1469-79. doi: 10.1017/S0031182011000746. Epub 2011 Aug 11. Review.

18.

Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.

Dicko A, Toure SO, Traore M, Sagara I, Toure OB, Sissoko MS, Diallo AT, Rogier C, Salomon R, de Sousa A, Doumbo OK.

BMC Public Health. 2011 Jul 18;11:573. doi: 10.1186/1471-2458-11-573.

19.

Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance.

Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE.

Clin Infect Dis. 2011 Aug 1;53(3):224-30. doi: 10.1093/cid/cir376.

20.

Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children.

Cairns M, Ghani A, Okell L, Gosling R, Carneiro I, Anto F, Asoala V, Owusu-Agyei S, Greenwood B, Chandramohan D, Milligan P.

PLoS One. 2011 Apr 20;6(4):e18947. doi: 10.1371/journal.pone.0018947.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk